Another study of the relationship between cognitive impairment and IGF-1 and IGFBP-3 found that plasma IGF-1 concentrations were not associated with dementia incidence, while doubling of plasma IGFBP-3 concentration reduced the risk ratio of dementia by 23% (Almeida et al., 2018). This evidence concerns the gene IGF1 and dementia.